Week1, 2021
1. Influenza activity remains unusually low nationwide, with respiratory specimens testing positive for influenza at a rate of 0.4% for clinical labs and 0.3% cumulatively since late September 2020.
2. Of clinical lab positives this week, 20.4% were Influenza A and 79.6% were Influenza B. Cumulative totals are similar, with 36.4% Influenza A and 63.6% Influenza B.
3. Public health labs reported only 4 positives this week, of which 75% were Influenza A and 25% were Influenza B; no subtypes were identified this week.
4. Outpatient visits for influenza-like illness (ILI) represented 1.7% of visits, similar to the previous week (1.6%) but below the national baseline of 2.6%.
5. There were no new pediatric influenza-associated deaths reported this week, with one pediatric death reported so far this season.
6. Pneumonia, influenza, or COVID-19 (PIC) accounted for 17.2% of deaths, well above the epidemic threshold of 7.0%; most PIC deaths were attributed to COVID-19.
7. A total of 129 influenza-associated hospitalizations have been reported so far, significantly lower than average for this point in the season.
8. The CDC emphasizes flu vaccination and antiviral treatments, with an annual flu vaccine remaining the best prevention method.
9. Healthcare-seeking behaviors and ILI data remain significantly influenced by the ongoing COVID-19 pandemic, complicating interpretation and reporting.
10. Flu activity may increase in the coming months, but trends remain unpredictable due to suppressed influenza transmission and concurrent COVID-19 surveillance and changes in healthcare utilization.